← Open Payments lookup

CANDICE CASE: Open Payments

NPI 1649042987 · OWINGS MILLS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,294 in 63 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $911 · 2025 $1,294

Food & beverage: $1,294
CompanyPaymentsAmount
GlaxoSmithKline, LLC.16$322
Verona Pharma, Inc.13$182
AstraZeneca Pharmaceuticals LP8$180
GENZYME CORPORATION3$82
Axsome Therapeutics, Inc.3$81
Grifols USA, LLC3$67
HARMONY BIOSCIENCES LLC3$66
Electromed, Inc.2$58
Lilly USA, LLC3$54
Takeda Pharmaceuticals U.S.A., Inc.2$53

Products named: NUCALA, Ohtuvayre, TRELEGY ELLIPTA, DUPIXENT, AIRSUPRA, Sunosi, FASENRA, Prolastin-C Liquid.

Industry payments across MD — which companies pay providers there.